XSpray Pharma AB 

€2.6
0
-€0.02-0.95% Wednesday 06:04

Statistics

Day High
2.6
Day Low
2.6
52W High
3.2
52W Low
2.24
Volume
0
Avg. Volume
14
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q4 2025
Next
0.16
0.49
0.82
1.16
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6XP.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partnership agreements with EVERSANA for the commercialization of Dasynoc, as well as with NerPharMa S.r.l for production of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Per Andersson Ph.D.
Employees
26
Country
Sweden
ISIN
SE0009973563

Listings

0 Comments

Share your thoughts

FAQ

What is XSpray Pharma AB stock price today?
The current price of 6XP.MU is €2.6 EUR — it has decreased by -0.95% in the past 24 hours. Watch XSpray Pharma AB stock price performance more closely on the chart.
What is XSpray Pharma AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange XSpray Pharma AB stocks are traded under the ticker 6XP.MU.
When is the next XSpray Pharma AB earnings date?
XSpray Pharma AB is going to release the next earnings report on May 06, 2026.
How many employees does XSpray Pharma AB have?
As of April 16, 2026, the company has 26 employees.
In which sector is XSpray Pharma AB located?
XSpray Pharma AB operates in the Other sector.
When did XSpray Pharma AB complete a stock split?
XSpray Pharma AB has not had any recent stock splits.
Where is XSpray Pharma AB headquartered?
XSpray Pharma AB is headquartered in Solna, Sweden.